Reverse Transcriptase Inhibitors: all 1,328 studies that test it
Page 9 of 14. Open to participants first (42), then studies with results posted, then the rest; newest registration first within each.
- Raltegravir as Early Therapy in African-Americans Living With HIV StudyCompletedNCT00667433Phase 1
- ADVANCE Study: A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) + Adefovir Dipivoxil in Patients With Hbe(-) Chronic Hepatitis BCompletedNCT00661076Phase 3
- Study of Viral Load Decay Rates in HIV Infected Participants Starting Treatment With Raltegravir (RAL) and Emtricitabine/Tenofovir Disoproxil Fumarate (TDF)CompletedNCT00660972Phase 1
- A Single-arm Study Evaluating the Efficacy and Safety of Telbivudine With or Without add-on Tenofovir in Adults With HBeAg-positive Chronic Hepatitis B (CHB)CompletedNCT00651209Phase 4
- Metabolic Impact Assessment of Tenofovir Disoproxil Fumarate on Non-HIV-1 Infected Healthy Adult Male VolunteersCompletedNCT00648817Phase 4
- Study to Evaluate Changes in Limb Fat When Switching From a Thymidine AnalogueCompletedNCT00647946Phase 2
- Efficacy and Safety of Switching From Retrovir to Tenofovir or Abacavir in HIV-infected PatientsCompletedNCT00647244Phase 4
- Open Label Study of Pharmacokinetics and Safety of Dose of Adefovir Dipivoxil in Children and Adolescents With HBVCompletedNCT00645294Phase 1/2
- PK Study of Tacrolimus and Cyclosporine When Co-Administered With Adefovir Dipivoxil in Post-Liver Transplant PatientsCompletedNCT00644761Phase 2
- An Open-Label Study of Emtricitabine in Combination With Other Antiretroviral Agents in HIV Infected Pediatric SubjectsCompletedNCT00642291Phase 2
- An Extension Study for Patients Previously Treated With ARQ 501CompletedNCT00622063Phase 1/2
- Three Generic Nevirapine-Based Antiretroviral Treatments in Chinese Patients:Multicentric Observation CohortCompletedNCT00618176Phase 4
- ROCKET I - Randomized Open Label Switch for Cholesterol Elevation on Kivexa Evaluation TrialCompletedNCT00615810Phase 4
- Bioequivalency Study of Zidovudine Under Fasting ConditionsCompletedNCT00602550Not applicable
- Bioequivalency Study of Zidovudine Under Fed ConditionsCompletedNCT00601562Not applicable
- Interventional Study of Mucosal and Antimicrobial Responses to Repeated Vaginal Applications of Tenofovir Gel in HIV Uninfected WomenCompletedNCT00594373Phase 1
- Evaluation of 4 New Simplified Antiretroviral Treatments in Naive HIV-1 Infected Patients in Africa (ANRS 12115 DAYANA)CompletedNCT00573001Phase 3
- Pharmacokinetic Study of the Vaginal Microbicide Agent 1% Tenofovir GelCompletedNCT00561496Phase 1
- Incidence and Severity of Neuropsychiatric Adverse Events of Efavirenz Given as a Stepped Dosage vs. the Usual DosageCompletedNCT00556634Phase 4
- Effects of Anti-HIV Drugs on the Hepatitis C Virus (HCV) in Adults Infected With Both HCV and HIVCompletedNCT00545558Phase 1
- Comparison of Epzicom and Truvada for the Initial Once Daily HIV TreatmentCompletedNCT00544128Phase 4
- Pediatric Expanded Access Program-Oral Solution (0831-908)CompletedNCT00543530Phase 3
- Blood Levels of Tenofovir Gel in HIV Uninfected Pregnant Women Planning Cesarean DeliveryCompletedNCT00540605Phase 1
- The CogNaive Study: Assessing Changes in Neurocognitive Function in Treatment Naïve HIV-1 Positive SubjectsCompletedNCT00540137Phase 4
- Randomized Clinical Trial to Assess the Efficacy and Safety of Concomitant Use of Rifampicin and Efavirenz 600 X 800mgTerminatedNCT00533390Phase 4
- Once-daily Antiretroviral Therapy in HIV-1 Infected Patients With CD4+ Cell Counts Below 100 Cells/MclCompletedNCT00532168Phase 4
- TMC 125 Blood Levels StudyCompletedNCT00531323Phase 1
- Measure of Pharmacokinetic Parameters and Adherence With MEMS in Naive HIV Infected Patients Treated With Reyataz Once Daily Combined With Norvir and TruvadaCompletedNCT00528060Phase 2
- HIV Antiretroviral Drugs and MetabolismStatus unknownNCT00525239Not applicable
- An Exploratory Biomarker Study of ARQ 501 in Patients With Advanced Solid TumorsCompletedNCT00524524Phase 1
- A Study to Determine the Best Dose of Antivirals in Patients With Both TB and HIVTerminatedNCT00523458Phase 4
- A Study to Investigate Whether the Immediate Use or Deferred Use of an Anti-viral Drug Lamivudine Will Help to Better Safe-guard the Delivery of Chemotherapy in Patients With Cancer Who Are Also Hepatitis B CarriersCompletedNCT00516945Not applicable
- Efficacy and Safety of Clevudine Compared With Adefovir in Patients With Chronic Hepatitis Due to Hepatitis B VirusTerminatedNCT00496158Phase 3
- Efficacy and Safety of Clevudine Compared With Adefovir in Patients With HBeAg Positive Chronic Hepatitis Due to Hepatitis B VirusTerminatedNCT00496002Phase 3
- Comparison of Nevirapine and Efavirenz for the Treatment of HIV-TB Co-infected Patients (ANRS 12146 CARINEMO)CompletedNCT00495326Phase 2/3
- Study of Combivir for Patients With Primary Biliary CirrhosisCompletedNCT00490620Phase 2/3
- A Randomized Study Comparing Lamivudine Versus Adefovir Dipivoxil for Prevention of zHBV Reactivation in HBsAg Seropositive Patients Undergoing Cytotoxic ChemotherapyStatus unknownNCT00489151Not applicable
- Efavirenz-based Versus Nevirapine-based Antiretroviral Therapy Among HIV-infected Patients Receiving RifampinCompletedNCT00483054Phase 3
- Pharmacokinetic and Efficacy of SQV/r 1500/100 Plus Tenofovir/Emtricitabine 300/200 mgWithdrawnNCT00476983Phase 2/3
- Efficacy of Tenofovir and Emtricitabine in ARV-naive Patients With HIV/HBV Co-infectionCompletedNCT00476463Phase 2
- A Pharmacokinetic Study of Once Daily Efavirenz 400 mg Versus 600 mg in Thai HIV-1 Infected SubjectsCompletedNCT00476424Phase 2
- Pharmacokinetics of Emtricitabine/Tenofovir/Efavirenz in HIV-infected Patients With TuberculosisStatus unknownNCT00474435Phase 2
- Clinical Trial to Assess the Efficacy of Darunavir/Ritonavir (DRV/r), Etravirine (ETV) and Raltegravir (MK-0518) in HIV Patients With Resistant VirusesCompletedNCT00460382Phase 2
- Comparison of Plasma Drug Levels of Triomune 40 With Those of the Originator ProductsCompletedNCT00455585Phase 4
- Safety and Effectiveness Study of a Candidate Vaginal Microbicide for Prevention of HIVCompletedNCT00441298Phase 2
- Safety, Tolerance, Pharmacokinetic and Antiviral Study of Amdoxovir in Combination With Zidovudine in Adults With HIVCompletedNCT00432016Phase 1/2
- Topical AS101 for Treatment of FAGA (Female Androgenetic Alopecia) in Menopause WomenStatus unknownNCT00418249Phase 2
- Study to Evaluate the Replacement of Reverse Transcriptase Nucleoside/Nucleotide Inhibitors by Nevirapine in Patients on Triple Treatment With Analogues OnlyCompletedNCT00415090Phase 4
- TMC125-C203: Phase II Randomized (Patients Are Assigned Different Treatments Based on Chance), Placebo Controlled Dose Escalating Trial of TMC125 in HIV-1 Infected PatientsCompletedNCT00412646Phase 2
- Trial of Telbivudine Combination Therapy vs. Continued Adefovir MonotherapyWithdrawnNCT00409019Phase 4
- Safety Study of Elvucitabine in HIV-1 SubjectsCompletedNCT00405249Phase 2
- Efavirenz to Nevirapine Switch and Low-Density Lipoprotein (LDL)-DyslipidemiaCompletedNCT00405171Phase 4
- Drug Interaction - Oral ContraceptiveCompletedNCT00399685Phase 1
- Efficacy and Tolerance of Peg-interferon Alpha 2a Added to Tenofovir and Emtricitabine in AgHBe Positive HBV-HIV Co-infected PatientsCompletedNCT00391638Phase 2/3
- Immune Reconstitution in naïve HIV Patients With CD4 <100 Cells/mL When Treated With Lopinavir or Efavirenz.TerminatedNCT00386659Phase 4
- Atazanavir or Lopinavir in HIV Post-exposure ProphylaxisCompletedNCT00385645Phase 4
- HIV/AIDS Kaposis Sarcoma: Comparison of Response to HAART vs HAART Plus CXTCompletedNCT00380770Phase 4
- A Randomized Controlled Trial of Lamivudine in Acute Hepatitis BCompletedNCT00380614Phase 4
- Open-Label, 48-Week Extension Study of Elvucitabine in Combination With Background Antiretroviral Therapy (ART) for Participants Who Have Completed Study ACH443-014ACompletedNCT00380159Phase 2
- Single Tablet Regimen (STR) Simplification Study for HIV-1 Infected PatientsCompletedNCT00365612Phase 4
- Drug Interaction Study With Famotidine, Atazanavir, and Atazanavir/Ritonavir/TenofovirCompletedNCT00365339Phase 1
- A Study of ARQ 501 in Patients With Squamous Cell Carcinoma of the Head and NeckCompletedNCT00358930Phase 2
- Antiretroviral Switch From Didanosine to Tenofovir in HIV/HCV Co-infected PatientsCompletedNCT00358696Phase 4
- Dose Finding Confirmation of Atazanavir With Ritonavir and Efavirenz (ATV/RTV + EFV) in Healthy SubjectsCompletedNCT00357188Phase 1
- Study to Evaluate the Influence of Nevirapine to Atazanavir in Steady State Equilibrium in HIV PatientsCompletedNCT00355719Phase 4
- A Trial To Study The Effect Of Lamivudine In Adult Patients Who Suffer From Chronic Hepatitis B AloneCompletedNCT00354653Phase 4
- Backup With Combivir or Single Dose (SD) Truvada in Order to Avoid Non-nucleoside Reverse Transcriptase Inhibitor (NNRTI) Resistance After SD Nevirapine for the Prevention of Mother-to-child Transmission (PMTCT)CompletedNCT00346567Not applicable
- Safety and Durability ofTenofovir and a Cell Cycle Agent for Viral SuppressionCompletedNCT00344981Not applicable
- Clinical Utility Of Genetic Screening For HLA-B*5701, On Susceptibility To Abacavir HypersensitivityCompletedNCT00340080Phase 4
- Study to Evaluate Changes in CD4 on Replacing TDF With ABC or DDI+TDF With ABC+3TCCompletedNCT00338390Phase 3
- Pharmacokinetic Study Of EPZICOM TabletCompletedNCT00337922Phase 4
- To Determine if There Are Pharmacokinetic Interactions at Plasma or Intracellular Level Between Nucleosides and TenofovirCompletedNCT00335192Phase 4
- Tenofovir/Emtricitabine for PMTCT in Africa and Asia (ANRS 12109 TEmAA)CompletedNCT00334256Phase 2
- Safety and Efficacy of Two Once Daily Anti Retroviral Treatment Regimens Along With Anti-tuberculosis TreatmentStatus unknownNCT00332306Phase 3
- Safety Study of Once a Day ART and Opiate Substitute.CompletedNCT00324688Phase 4
- SONETT: Switch Study to Once Daily HIV Treatment Regimen With TruvadaCompletedNCT00323687Phase 4
- SWEET: Once Daily Truvada Versus Twice Daily Combivir for the Treatment of HIV InfectionCompletedNCT00323544Phase 3
- Comparison of Abacavir Following Once-Daily And Twice-Daily Administration In HIV Infected SubjectsCompletedNCT00320307Phase 1
- Antiretroviral Treatment Simplification Study With Efavirenz + Abacavir + 3TC Once DailyCompletedNCT00314626Phase 3
- Drug Levels of Tablet and Liquid Forms of Lamivudine, Nevirapine, and Stavudine in HIV Infected Thai ChildrenCompletedNCT00312091Phase 1/2
- Study of Once Daily Elvucitabine Versus Lamivudine in Participants With a Documented M184V MutationCompletedNCT00312039Phase 1/2
- Safety and Efficacy Study of ARQ 501 in Adult Patients With LeiomyosarcomaCompletedNCT00310518Phase 2
- Study to Determine the Pharmacokinetic Behavior of Antiretroviral Drugs in Patients Infected by HIVCompletedNCT00307502Phase 1
- Study Comparing the Safety of Switching From Lamivudine to Adefovir Dipivoxil Versus Overlapping Lamivudine and Adefovir Before Adefovir Dipivoxil Monotherapy in Patients With Chronic Hepatitis BCompletedNCT00307242Phase 4
- Randomized, Double-Blind Study Comparing Dexelvucitabine (DFC) to Lamivudine (3TC) in Subjects With Resistance to NRTIs, PIs, and NNRTIsTerminatedNCT00300573Phase 2
- Modification of Doses of Efavirenz According to Its Blood Concentration in HIV PatientsCompletedNCT00299091Phase 4
- Quality of Life and Changes in Metabolism of Lipids and Glucose After Switching to a Nevirapine-based Regimen in HIV+ PatientsCompletedNCT00274001Phase 4
- Pharmacokinetic Study of Interaction Between Nevirapine and Methadone in HIV-1 Infected, Opioid-dependent AdultsCompletedNCT00273988Phase 4
- Trial to Evaluate Steady State Pharmacokinetic Parameters, Efficacy and Safety of Nevirapine in Antiretroviral Drug naïve Pediatric PatientsCompletedNCT00273975Phase 2
- Zidovudine Plus Lamivudine in HTLV-I-associated Myelopathy: a Randomised TrialCompletedNCT00272480Phase 2/3
- Phase II Comparator Study of Substitution of Tenofovir or Abacavir Receiving Thymidine Analogue as Part of HAART.CompletedNCT00270556Phase 2
- Drug Interaction Study Between Antimalarial and Anti-HIV MedicationsCompletedNCT00266058Phase 1
- Blood Levels of Anti-HIV Drugs Used in Combination Regimens in HIV Infected ChildrenCompletedNCT00260078Phase 1/2
- Once a Day (QD) - Twice a Day (BID) Clinical Trial: Didanosine, Lamivudine and Efavirenz Versus Zidovudine, Lamivudine and Efavirenz in the Starting Treatment of HIVCompletedNCT00256828Phase 4
- TMC125-C216: A Phase III Study to Investigate the Efficacy, Tolerability and Safety of TMC125 as Part of an Antiretroviral Regimen, Including TMC114/Ritonavir and an Investigator-selected Optimized Background, in HIV-1 Infected Patients With Limited to no Treatment Options.CompletedNCT00255099Phase 3
- TMC125-C206: A Phase III Study to Investigate the Efficacy, Tolerability and Safety of TMC125 as Part of an Antiretroviral Regimen, Including TMC114/Ritonavir and an Investigator-selected Optimized Background, in HIV-1 Infected Patients With Limited to no Treatment Options.CompletedNCT00254046Phase 3
- Evaluation of Viral Efficacy and Safety of a Reduced Dose of Stavudine (d4T): THE PHOENIX STUDYStatus unknownNCT00235222Phase 4
- Efficacy and Safety of Kaletra Monotheraphy Compared to Kaletra Based Triple Therapy to Treat HIV in Antiretroviral Naїve PatientsCompletedNCT00234923Phase 3
- When to Start Anti-HIV Drugs in Children Infected With HIV (The PREDICT Study)CompletedNCT00234091Phase 3
- Hepsera Versus Hepsera Plus Lamivudine for Treatment of Chronic Hepatitis B in Patients With Normal ALTCompletedNCT00230477Phase 4